SCHEMBL413550

SCHEMBL413550

Cc1cccc2c1CCC2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.52
BAD Q92934 1/20 0.52
TSHR P16473 1/20 0.43
ALOX12 P18054 1/20 0.43
ALDH1A1 P00352 4/20 0.41
NISCH Q9Y2I1 1/20 0.41
CES1 P23141 1/20 0.39
DRD4 P21917 1/20 0.39
RXRA P19793 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
NFKB1 P19838 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29892288 1.00 BCL2L1 (0.52) BCL2L1BADTSHRALOX12ALDH1A1
SCHEMBL598625 0.95 BCL2L1 (0.58) BCL2L1BADTSHRALOX12ALDH1A1
SCHEMBL30717272 0.95 BCL2L1 (0.58) BCL2L1BADTSHRALOX12ALDH1A1
SCHEMBL31011900 0.93 BCL2L1 (0.56) BCL2L1BADTSHRALOX12ALDH1A1
SCHEMBL5598514 0.93 BCL2L1 (0.56) BCL2L1BADTSHRALOX12ALDH1A1
SCHEMBL11352084 0.87
Dimethylamine SCHEMBL6542165 0.87 BCL2L1 (0.50) BCL2L1BADTSHRALOX12ALDH1A1
SCHEMBL12430498 0.82 BCL2L1 (0.41) BCL2L1BADALOX12ALDH1A1CES1
SCHEMBL7056082 0.80 BCL2L1 (0.41) BCL2L1BADTSHRALOX12ALDH1A1
SCHEMBL6904839 0.80 PARP1 (0.38) BCL2L1BADTSHRALOX12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115181594-A Novel automobile exhaust purifying agent 山东车互通石油化工有限公司 2022-10-14 CN claimed
US-8895789-B2 Fuel composition for use in gasoline engines SHELL OIL COMPANY (US) 2014-11-25 US claimed
US-12624231-B2 Organic solvent composition and paint composition comprising the same ANAME OF ASSIGNEE Innovation Co., Ltd. (KR) 2026-05-12 US disclosed
US-20250304567-A1 PYRROLIDIONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2025-10-02 US disclosed
US-20250282785-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2025-09-11 US disclosed
CN-119861156-A Method for pre-judging identification degree of high molecular material interfering fire scene gasoline inspection 中国人民警察大学(公安部国际执法合作学院、中国维和警察培训中心) 2025-04-22 CN disclosed
EP-4296321-B1 AROMATIC ORGANIC SOLVENT COMPOSITION AND PAINT COMPOSITION COMPRISING THE SAME SK INNOVATION CO LTD (KR) 2024-11-20 EP disclosed
US-20240182796-A1 PRODUCTION OF MONOAROMATIC HYDROCARBONS FROM HYDROCARBON FEEDSTOCKS SABIC GLOBAL TECHNOLOGIES BV (NL) 2024-06-06 US disclosed
CN-117897468-A Production of monoaromatics from hydrocarbon feedstocks 沙特基础工业全球技术有限公司 2024-04-16 CN disclosed
CN-115417743-B Fractional melting crystallization process for industrial naphthalene refined naphthalene 中建安装集团有限公司 2024-01-30 CN disclosed
CN-117451439-A System and method for collecting leakage of petrochemical water cooler 中国石油化工股份有限公司 2024-01-26 CN disclosed
EP-1261321-A2 CARBOXYLIC ACID AMIDES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND THE USE AND PRODUCTION THEREOF Boehringer Ingelheim Pharma KG (DE) 2002-12-04 EP disclosed
WO-2002074884-A1 CONTINUOUS PROCESS FOR OXIDATIVE DESULFURIZATION OF FOSSIL FUELS WITH ULTRASOUND AND PRODUCTS THEREOF SULPHCO, INC. (US) 2002-09-26 WO disclosed
US-20020099089-A1 Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and preparation BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2002-07-25 US disclosed
US-6362210-B1 ANTITUMOR, ANTICANCER AGENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-03-26 US disclosed
WO-2001007020-A2 CARBOXYLIC ACID AMIDES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND THE USE AND PRODUCTION THEREOF BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-02-01 WO disclosed
WO-1998000478-A1 DESULFURIZATION AND HYDROCARBON QUALITY ENHANCEMENT PROCESS INTERGLOBAL DESULFURIZATION SYSTEMS, INC. (US) 1998-01-08 WO disclosed
EP-0024440-B1 2,4,6-TRIKETOHEXAHYDROTRIAZINES CONTAINING ISOCYANATE GROUPS AND A PROCESS FOR THEIR PREPARATION CHEMISCHE WERKE HÜLS AG (DE) 1983-06-29 EP disclosed
US-3968163-A Preparation of 4 and 5-methylindanes MARION LABORATORIES, INC. (US) 1976-07-06 US disclosed
US-3968163-A Preparation of 4 and 5-methylindanes MARION LABORATORIES, INC. (US) 1976-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240182796-A1 PRODUCTION OF MONOAROMATIC HYDROCARBONS FROM HYDROCARBON FEEDSTOCKS HPD, HMOX1, HMOX2 BCL2L1 3653/4885BAD 2434/4885TSHR 4635/4885
US-20250304567-A1 PYRROLIDIONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE NFKBIA, IKBKG, IKBKB BCL2L1 1041/4885BAD 940/4885TSHR 4316/4885
US-12624231-B2 Organic solvent composition and paint composition comprising the same PIEZO1, DNMT3B, TRPA1 BCL2L1 863/4885BAD 1895/4885TSHR 3682/4885
US-20020099089-A1 Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and preparation TERT, NAT1, POT1 BCL2L1 1935/4885BAD 1354/4885TSHR 1693/4885
US-20250282785-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE NFKBIA, IKBKG, IKBKB BCL2L1 1669/4885BAD 983/4885TSHR 4220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.